Increased S100A4 expression is associated with increased Src and FAK activation in human pancreatic tumor tissues, and S100A4-deficient tumors show remarkably decreased FAK and Src activation in vivo in a pancreatic cancer mouse model (Fig. 4E and Supplementary Fig. S2). Here, SRC is linked to familial pancreatic carcinoma.